Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Predictmedix Ai Inc (OP: PMEDF )

0.0100 UNCHANGED
Streaming Delayed Price Updated: 3:33 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Predictmedix Ai Inc

< Previous 1 2 3 Next >
Predictmedix Receives Purchase Order Valued at $500k from MGM Healthcare for AI-Powered Safe Entry Stations to Enhance Healthcare Operations
Via ACCESSWIRE
Predictmedix’s Safe Entry Receives International Recognition in Major Indonesian Newspaper for its Healthcare Application
Via ACCESSWIRE
Predictmedix Expands on Non-Invasive AI-powered Impairment Detection Technology for Vertical-Specific Applications
Via ACCESSWIRE
Predictmedix Announces US Patent Grant for AI-Powered Impairment Detection Technology for Cannabis and Alcohol Screening
Via ACCESSWIRE
Predictmedix Deploys Safe Entry's Fit for Duty Screening at LongArm Engineering
Via ACCESSWIRE
Predictmedix Announces Production of AI-Powered Mobile Application to Rapidly Detect Impairment from Alcohol and Cannabis
Via ACCESSWIRE
Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry's Medical Device Regulatory Approval in Indonesia
Via ACCESSWIRE
Predictmedix Announces a Purchase Order for Safe Entry's Fit for Duty Screening in the Defence Sector
Via ACCESSWIRE
Predictmedix Announces Third-Party Independent Clinical Validation for AI-Powered Screening following 400 Patient Study at MGM Healthcare
Via ACCESSWIRE
Predictmedix Closes $612,500 Private Placement and Announces Listing on the Frankfurt Exchange
Via ACCESSWIRE
Predictmedix Provides Corporate Update on Key Technology Milestones and Commercialization Outlook for 2023
Via ACCESSWIRE
Predictmedix Provides Business and Technology Development Updates and Closes Final Tranche of Private Placement
Via ACCESSWIRE
Predictmedix Closes First Tranche of Private Placement
Via ACCESSWIRE
Predictmedix and Partners Launch Safe Entry Station as a Comprehensive Fit for Duty Screening Solution at Electra Mining Africa and National Safety Council's (NSC) Congress & Expo
Via ACCESSWIRE
Predictmedix Announces Accuracy Rates for Monitoring of Symptoms and Physiological Parameters
TORONTO, ON / ACCESSWIRE / July 25, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictmedix Announces Accuracy Rates for Monitoring of Symptoms and Physiological Parameters
Via ACCESSWIRE
Predictmedix Receives $1.85 Million Letter of Intent for 80 Safe Entry Stations from KaTron Defence Space and Simulation Technologies
TORONTO, ON / ACCESSWIRE / June 29, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence Cannabis
Exposures Artificial Intelligence Cannabis
EXCLUSIVE: Predictmedix Receives $1.85M LOI For 80 Safe Entry Stations From KaTron Defence Space And Simulation Technologies
Predictmedix Inc. (CSE: PMED) (OTCQB: PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI) has received a non-binding Letter of Intent 
Via Benzinga
Emerging Technologies Are Advancing The Urgent Need For Noninvasive Cannabis Impairment Detection
By Dr. Rahul Kushwah, Interim CEO, Predictmedix 
Via Benzinga
Predictmedix Secures Deployment of Safe Entry Stations at De Beers Forevermark Forum 2022
High Visibility, Revenue Generating Deployment Provides Predictmedix with Strong Industry Validation 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Predictmedix Reports Fiscal 2022 Financial Results
TORONTO, ON / ACCESSWIRE / June 1, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a proprietary... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence Cannabis
Exposures Artificial Intelligence Cannabis Product Safety
Predictmedix to Present at 12th Annual LD Micro Invitational
Interim CEO Dr. Rahul Kushwah to Present at 11:00 a.m. Pacific on June 7, 2022 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictmedix Showcases Safe Entry Station Technology at Major Las Vegas Entertainment Event
Placement at Major Las Vegas Venue Served as Live, High-Profile Demonstration of Safe Entry Station to Area Entertainment and Hospitality Sector Representatives TORONTO, ON / ACCESSWIRE / April 5, 2022... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictmedix Inc. Issues Shareholder Letter and Provides Corporate Update on Key Milestone Achievements
TORONTO, ON / ACCESSWIRE / February 10, 2022 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictmedix To Launch Infectious Diseases Clinical Trial in North American Hospital for FDA Medical Device Classification of Safe Entry Stations
Independent Study for Infectious Diseases Symptom Detection in a Clinical Setting to Provide Additional Third-Party Validation; Prerequisite Ahead of Planned FDA Certification as Class II Medical... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Predictmedix Announces Accuracy Rates for Alcohol and Cannabis Impairment Detection Technology and Provides Update on the Next Steps for Technology Commercialization
Upcoming Clinical trial in North American Hospital Expected to Provide Additional Third-Party Validation Ahead of Planned Commercial Launch TORONTO, ON / ACCESSWIRE / January 12, 2022 / Predictmedix... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence Cannabis
Exposures Artificial Intelligence Cannabis
Predictmedix Secures Inaugural Placement of Safe Entry Station at Health and Wellness Retreat in Ontario, Canada
Ste. Anne's Spa, an Ontario-Based Health and Wellness Retreat, to Rollout Safe Entry Station Solution to Ensure Safe Environment for Staff & Guests Health Retreat & Resort Market Represents Significant... 
From Predictmedix
Via AccessWire
Predictmedix Launches ThuraPass Safe Entry Program for Sports and Entertainment Industry in Conjunction with Uptown Sports Marketing
First Major Deployment at Formula One United States Grand Prix Successfully Identified COVID-19 Infected Staff Prior to Event Entry TORONTO, ON / ACCESSWIRE / November 3, 2021 / Predictmedix Inc.... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence COVID-19 Intellectual Property
Predictmedix Safe Entry Station Receives CE Mark Approval and ISO Certification for Commercialization in the European Union
Regulatory Approval Enables Commercialization in New, Leading Global Marketplaces TORONTO, ON / ACCESSWIRE / November 2, 2021 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence COVID-19 Intellectual Property
Predictmedix Deployed Safe Entry Stations at Formula 1 Aramco United States Grand Prix
Company Deployed 15 Safe Entry Stations at Circuit of the Americas in Austin, Texas to Screen Hospitality Suite Attendees and Catering Staff TORONTO, ON / ACCESSWIRE / October 25, 2021 / Predictmedix... 
From Predictmedix
Via AccessWire
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence COVID-19 Intellectual Property
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.